TrialBMC medicine2025

Agomelatine as adjunctive therapy with SSRIs or SNRIs for major depressive disorder: a multicentre, double-blind, randomized, placebo-controlled trial.

Yumeng Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.